Electroconvulsive therapy (ECT) is one of the most effective treatments available for severe depression, with response rates around 74% and full remission in roughly 62% of patients who complete a course of treatment. Those numbers far exceed what most medications achieve, especially for people who haven’t improved after trying multiple antidepressants. Despite its reputation, modern ECT looks nothing like its portrayals in old movies. It’s performed under general anesthesia, takes about 10 minutes per session, and remains a go-to option when other treatments have failed.
Rapid Relief From Severe Depression
The primary benefit of ECT is its ability to lift severe depression when medications can’t. In studies of patients with treatment-resistant major depression, about 74% responded to a course of ECT and 62% achieved full remission. For context, “treatment-resistant” typically means someone has tried two or more antidepressants without adequate improvement. At that stage, the odds of a new medication working drop significantly, making ECT’s success rate especially notable.
Speed is another advantage. Most antidepressants take four to six weeks to show their full effect. ECT often produces noticeable improvement within the first week or two of treatment. A typical course involves two to three sessions per week over three to four weeks, totaling six to twelve sessions. For someone in a psychiatric crisis, that faster timeline can be meaningful.
Strong Results in Bipolar Disorder
ECT works across both poles of bipolar disorder. In bipolar depression, response rates hover around 80%, comparable to its effectiveness in unipolar depression. But what surprises many people is how well it works for mania, too. A review spanning 80 years of clinical data, published in the American Journal of Psychiatry, found that roughly 80% of manic patients showed substantial improvement or full remission after ECT.
The results are particularly striking for medication-resistant mania. In one study of patients with rigorously defined medication resistance, none of the five patients treated with intensive drug combinations met response criteria. Among the 20 treated with ECT, 75% achieved remission. Mixed episodes, where symptoms of depression and mania overlap, also respond well, with remission rates between 56% and 76% depending on the study.
Improvement during manic episodes tends to happen quickly. Psychomotor agitation, the restless and driven quality of mania, often resolves within two to four sessions. Full resolution of symptoms typically occurs by the sixth treatment.
A Lifeline for Catatonia
Catatonia is a serious condition where a person may become unresponsive, stop speaking, refuse food, or hold rigid postures for hours. It can occur alongside mood disorders, schizophrenia, or medical conditions like autoimmune disease. ECT is one of the most reliable treatments, with response rates between 80% and 100% in acute cases.
The clinical evidence is compelling even in unusual situations. A 15-year-old with catatonia caused by lupus, who hadn’t responded to several other treatments, recovered after ECT. A man who remained catatonic for a year and a half following a heart attack improved with ECT when nothing else had worked. In acute catatonia, regardless of the underlying cause, resolution of symptoms can begin after just one or two sessions.
Chronic catatonia, particularly when it occurs alongside schizophrenia, tends to be less responsive. But for the acute form, ECT remains the most effective option available when initial treatment with sedative medications falls short.
Added Benefit in Treatment-Resistant Schizophrenia
ECT is not a standalone treatment for schizophrenia, but combining it with antipsychotic medication produces better results than medication alone. A meta-analysis of 11 randomized trials covering 818 patients found that adding ECT to antipsychotic treatment led to significantly greater symptom improvement. The combination roughly doubled remission rates compared to antipsychotics alone.
The benefits showed up fast, with measurable differences appearing within the first one to two weeks. Positive symptoms like hallucinations and delusions improved the most. The effect on negative symptoms, such as emotional flatness and social withdrawal, was less consistent across studies. Still, for patients stuck on antipsychotics that aren’t fully controlling their symptoms, ECT augmentation offers a meaningful step forward.
Reduction in Suicidal Thinking
ECT’s rapid action makes it particularly valuable when someone is actively suicidal. A meta-analysis published in BMJ Mental Health found that ECT was associated with a 47% reduction in suicide risk at three months of follow-up. That short-term benefit matters enormously for getting someone through a crisis period. The association did not hold at longer follow-up intervals of six or twelve months, which underscores the importance of continuing treatment after the ECT course ends rather than relying on ECT alone.
Keeping Depression From Coming Back
One challenge with ECT is that depression can return after a successful course. That’s where maintenance ECT comes in: ongoing sessions, typically once every two to four weeks, designed to prevent relapse. A meta-analysis of clinical trials found that combining maintenance ECT with antidepressant medication reduced the risk of recurrence to about 28%, and this combination was significantly more effective than taking antidepressants alone. Antidepressants by themselves had a recurrence rate around 31%.
Maintenance ECT without medication didn’t show a clear advantage over medications alone. The takeaway is that the best long-term strategy appears to be pairing occasional ECT sessions with ongoing antidepressant therapy rather than relying on either one in isolation.
What the Modern Procedure Looks Like
If you’re considering ECT, knowing what actually happens can ease a lot of anxiety. You’ll be given general anesthesia, so you’re fully asleep and unaware during the procedure. A muscle relaxant prevents your body from moving during the brief, controlled seizure that the treatment induces. The entire session, from falling asleep to waking up, typically lasts about 10 minutes. You’ll spend another 30 to 60 minutes in a recovery area afterward.
Common side effects after a session include headache, mild muscle soreness, nausea, and drowsiness. These are generally short-lived and manageable with basic pain relievers.
Cognitive Side Effects and Electrode Placement
Memory effects are the most discussed concern with ECT, and the choice of electrode placement plays a big role. There are two main approaches: right unilateral, where both electrodes are placed on one side of the head, and bilateral, where electrodes are placed on both sides.
Right unilateral ECT produces fewer cognitive side effects. Patients treated this way experience less post-treatment confusion, better preservation of general cognitive function, and less impact on verbal memory compared to bilateral placement. Both approaches can cause some decline in autobiographical memory, the ability to recall personal events from your past, that may persist for at least three months. But this effect is significantly more pronounced with bilateral placement.
Right unilateral ECT is effective for most patients and is often the starting point. Bilateral placement may be considered when a faster or stronger response is needed, but the tradeoff in cognitive effects is real. This is a conversation worth having with your treatment team so the approach can be tailored to your situation.